Phase 2 × Completed × Amplified Fragment Length Polymorphism Analysis × Clear all Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Phase 2 Completed
5 enrolled 10 charts
OMEGA
Phase 2 Completed
62 enrolled 6 charts
CML0408
Phase 2 Completed
129 enrolled
S0916, MLN1202 in Treating Patients With Bone Metastases
Phase 2 Completed
44 enrolled 7 charts
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
45 enrolled 9 charts
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Phase 2 Completed
73 enrolled 16 charts
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2 Completed
53 enrolled 10 charts
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
Phase 2 Completed
47 enrolled 10 charts
Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
Phase 2 Completed
33 enrolled 7 charts